from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2617c/-

LFCtreatmentdescriptionclass of inhibitor

0.854

Amikacinug/mL Amikacintranslation

0.608

Cap5-10ug/mL Capreomycintranslation

1.252

Rox10-50 ug/mL Roxithromycintranslation

-0.045

SM2-5 ug/mL Streptomycintranslation

0.883

Tet5-10 ug/mL Tetracyclinetranslation

-0.311

Rif0.2-5ug/mL Rifampicintranscription

-0.137

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.114

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

0.251

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.864

CPZ10-50 ug/mL Chlorpromazinerespiration

1.906

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.651

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.721

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

0.446

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.843

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.246

Econazole10-24 ug/mL Econazole (azole drug)respiration

2.411

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.432

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

1.130

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.388

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.176

KCN5-20 ug/mL Potassium cyaniderespiration

-0.260

NaN30.2-2 mM Sodium aziderespiration

0.050

Nigericin50 uM Nigericinrespiration

0.026

TRC10-150 ug/mL Triclosanrespiration

-0.511

TRZ10-25 ug/mL Thioridazinerespiration

-0.476

Valinomycin0.5-10 uM Valinomycinrespiration

-1.457

ZnSO42 mM ZnSO4respiration

-0.276

menadione6-10 ug/mL Menadionerespiration

-0.072

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.236

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.415

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

1.616

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.055

NRP_1Non-replicating persistence stage 1dosRassociated

-0.166

Amp0.2mg/mL AmpicillincellWall

-0.220

Cephalexin20-100 ug/mL CephalexincellWall

-0.127

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.800

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.576

EMB10-20 ug/mL EthambutolcellWall

0.043

Eta12-40 ug/mL EthionamidecellWall

0.254

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.067

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.038

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.815

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.033

BZA0.12 mg/mL BenzamidearomaticAmides

0.162

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.872

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

2.056

H2O24 mM hydrogen peroxideDNAdamaging

0.025

Levo10 ug/mL LevofloxacinDNAdamaging

-0.246

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.077

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.138

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.444

UVUV-irradiationDNAdamaging

3.052

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.223

Antimycin12.5-50 ug/mL Antimycin A?

-0.125

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.163

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.360

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.543

PA8240.2-2 ug/mL PA-824?

-0.508

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.336

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.578

Verapamil50 uM Verapamil?

-0.342

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.178

methoxatin10-20 ug/mL Methoxatin?